Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02111746 · ClinicalTrials.gov registry record · Phase 4
PAIN - Postoperative Analgesia INvestigation
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 350
- Enrollment target
NCT02111746 is a Phase 4 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 350 participants.
The verdict
NCT02111746, a Phase 4 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 350 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the efficacy of the intraoperative injection of prolonged acting (liposomal) bupivacaine in postoperative pain control after truncal surgical incisions.
Interventions
- DRUG Exparel
- DRUG Bupivacaine hydrochloride
- DRUG Patient Controlled Analgesia (PCA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2013-11-20 |
| Est. Completion | 2017-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02111746
The ClinicalTrials.gov registry entry for NCT02111746 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Exparel is the first listed.
NCT02111746 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02111746 about?
NCT02111746 is a clinical study titled "PAIN - Postoperative Analgesia INvestigation". The purpose of this study is to assess the efficacy of the intraoperative injection of prolonged acting (liposomal) bupivacaine in postoperative pain control after truncal surgical incisions.
What is the current status of trial NCT02111746?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 350 participants. The study started on 2013-11-20. Estimated completion is 2017-06-30.
What interventions are being tested in trial NCT02111746?
The interventions under investigation include: Exparel (DRUG), Bupivacaine hydrochloride (DRUG), Patient Controlled Analgesia (PCA) (DRUG).
Who is sponsoring clinical trial NCT02111746?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.